A 5-year study offers reassurance.
A 5-year study offers reassurance that infants born to women who experience tachystytole during cervical ripening and labor induction are not more likely to have adverse outcomes. The findings were reported in Gynecologic and Obstetric Investigation.
Researchers from the University of Mississippi looked at data over a 5-year period from 905 women who were undergoing cervical ripening and subsequent labor induction. Significant uterine tachysystole was defined as ≥6 contractions in each of 2 consecutive 10-minute windows. Women with ≥3 episodes of tachysystole were compared with women with no such episodes.
Over the study period, 631 of the participants had no tachysystole, 143 had 1 or 2 episodes, and 131 had ≥3 episodes (P=0.991). Fewer of the women with tachysystole (28.2% vs 34.1%) delivered via cesarean but the difference was not statistically significant.
In the women with tachysystole, non-reassuring fetal tracings were more common (14.4% vs 21.4%; P=0.017) but 5-minute Apgar scores and umbilical cord pH and base excess did not differ between the 2 groups.
Study shows a healthy prenatal diet could be upstream obesity prevention strategy
December 26th 2024"Our findings support the recommendation of a healthy diet based on the current guidelines (as measured by the HEI) during pregnancy, since it may reduce patterns of infant growth outside reference ranges."
Read More
S1E4: Dr. Kristina Adams-Waldorf: Pandemics, pathogens and perseverance
July 16th 2020This episode of Pap Talk by Contemporary OB/GYN features an interview with Dr. Kristina Adams-Waldorf, Professor in the Department of Obstetrics and Gynecology and Adjunct Professor in Global Health at the University of Washington (UW) School of Medicine in Seattle.
Listen
Early pregnancy cannabis use high in states with recreational legalization
November 11th 2024A population-based time-series analysis California before, during and after legalization show a rising trend in women using cannabis while pregnancy especially when the state has legalized the drug.
Read More
Similar delivery times between misoprostol dosages among obese patients reported
May 29th 2024A recent study found that obese patients undergoing induction of labor experienced similar delivery times regardless of whether they received 50 μg or 25 μg of vaginal misoprostol, though multiparous patients showed faster delivery with the higher dosage.
Read More